Late Stent Malapposition After Drug-Eluting Stent Implantation

Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation.

PURPOSE To evaluate the impact of pre-procedural coronary plaque composition assessed by virtual histology intravascular ultrasound (VH-IVUS) on late stent malapposition assessed by optical coherence tomography (OCT) following drug-eluting stent (DES) implantation. MATERIALS AND METHODS The study population consisted of 121 patients (121 lesions) who underwent both pre-procedural VH-IVUS and ...

Very late stent thrombosis after implantation of drug eluting stent.

A case of late stent occlusion of a Sirolimus eluting Cypher stent (Cordis, Johnson and Johnson) presenting as acute ST elevation myocardial infarction 22 months after deployment is reported. The possible mechanisms are discussed.

Stent thrombosis after drug eluting stent implantation.

ince stent thrombosis (ST) is one of the serious and mortal complications after percutaneous coronary intervention (PCI), especially drug-eluting stent (DES) implantation, we are eager that the means of predicting and preventing ST be established. Several studies have reported an association between inflammation and stent thrombogenicity. In a clinical setting, Hwang et al1 reported a positive ...

Progression of late stent malapposition beyond 2 years after sirolimus-eluting stent implantation.

drug-eluting stent fracture within 6 days after stent implantation